CAMP4 Therapeutics Corp CAMP

US Biotechnology

$3.45 ▼ -0.58% ($-0.02)

🗓️ Earnings Next Week

Open $3.45

Prev Close $3.47

Day Range $3.34 – $3.54

52W Range $1.32 – $7.75

Market Cap $179.14M

Beta -22.80

EPS (TTM) $-2.24

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2024-10-11
Shares Out.	51,930,000
Website	camp4tx.com/ ↗
Phone	16176518867
Employees	48
Revenue	$1.3M
Gross Profit	$1.3M
Net Income	-$18.3M
Free Cash Flow	-$26.2M
Total Assets	$105.5M
Total Liabilities	$74.6M
Equity	$30.9M

About CAMP4 Therapeutics Corp

Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. The company focuses on genetic diseases of the central nervous system and liver. Its pipeline products include CMP-CPS-001 and CMP-SYNGAP. The company operates as a single operating segment, R&D, which engages in the development of a new class of RNA-based therapeutics to treat a broad range of genetic diseases.

CAMP4 Therapeutics Corp is a publicly traded company under the ticker symbol CAMP on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.